The alteration of a specific sequence of DNA using site-directed mutagenesis (SDM) provides an effective tool to probe the structure and function of gene products. With the advent of polymerase chain reaction (PCR), several new techniques were developed that facilitate SDM. An oligonucleotide containing mismatches at the desired site of mutation is used to generate a population of mutant fragments in the successive cycling.
However, during the design of an appropriate methodology, several difficulties arise. The use of thermostable Taq DNA polymerase, which lacks proofreading ability, leads to a reduction in the fidelity of the amplified DNA (3) . In addition, TaqDNA polymerase is known to place a 3 ′ overhang of a single base pair on amplified DNA, which often presents difficulties in cloning attempts. Most significantly, PCR is limited by the fact that sequence alterations must be located at the ends of the target sequence.
To address this final concern, some methods of PCR-based mutagenesis have focused on the generation of two overlapping fragments containing the desired mutation. The fragments are generated with two complementary mutant oligonucleotides and one other oligonucleotide flanking each side of the target sequence. The methods are differentiated by the manner in which they seek to fuse these overlapping fragments. The fused fragment is successively subcloned using convenient restriction sites flanking the region of interest. One protocol, termed the "megaprimer" method, calls for PCRbased generation of a long mutant fragment that is subsequently used as a primer in a second round of PCR, extending the mutant fragment to the other side of the mutation (3, 4, 8) . Such a method has been found to be technically difficult (5). More troublesome, however, is the fact that the singlestranded DNA overhang on the product of the first PCR often becomes misincorporated into the final product of the second PCR (9) . Even using proofreading polymerases, which decrease the risk of undesired mutations in a single round of PCR, a great threat to fidelity is posed by the megaprimer method because it requires two full rounds of PCR, twice the number of cycles required by the method presented here.
It has been suggested that if a convenient restriction site exists in the native sequence in the vicinity of the desired mutation, fusion of overlapping fragments can be carried out by ligating the ends generated by digestion (6) . Similar methods calling for digestion using class 2S restriction enzymes have been developed (10) . A recognition sequence incorporated into the end of the mutagenic primers allows for digestion downstream of the restriction site and fusion of the mutant fragments. However, significant drawbacks of such methods include the synthesis of costly, long primers and no allowance for screening of mutant plasmids because of the nature of class 2S enzymes, whereby the recognition site is lost after digestion.
Often, silent mutations resulting from transformation of mutagenized plasmids have been used to aid in the screening of colonies by adding or removing restriction sites while leaving the protein product unchanged by taking advantage of codon redundancy. In an effort to expand the use of the silent mutation and avoid the difficulties of other SDM methods, we present a method for SDM that uniquely makes use of a silent mutation adding a restriction site. The method maximizes generation of mutated product and maintains its fidelity in several ways such as: ( i ) it requires only a single round of PCR, ( ii ) it allows for rapid screening at an early stage to confirm the presence of the mutation, ( iii ) it results in high-efficiency, sticky-end ligation and ( iv ) it minimizes the size of the PCR-derived fragment to avoid undesired mutations. It serves as a viable alternative to the class 2S method of SDM because it allows for cost saving on primer synthesis and screening of mutant products using the incorporated restriction site. The mutagenesis reaction was performed on the OYE1gene cloned into the pET expression system as detailed in Saito et al. (7) . PCRs were conducted in a GeneAmp ® PCR System 2400 (Perkin-Elmer, Norwalk, CT, USA). The primer selection method and primer sequences are outlined in Figure  1 . Bst XI and Apa I were selected as the unique restriction sites on either side of the region to be mutated. Sequencing/ -PCR primers were designed to flank the region defined by the two wild-type restriction sites. The mutagenic primers encode the desired mutation and a silent mutation introducing a Cfo I restriction site.
Two PCRs were carried out to generate upstream and downstream fragments. Reactions were carried out in a total volume of 100 µ L containing 200 µ M dNTPs, 50 ng template OYE1-pET plasmid DNA, 1 µ M required primers (detailed above), 2.5 U TaqDNA polymerase, 1.5 mM MgCl 2 , 10 mM TrisHCl, 50 mM KCl (pH 8.3). The PCR mixture was held at 94°C for 5 min and then cycled 25 times at 94°C for 45 s, 55°C for 1 min and 72°C for 2 min followed by 15 min at 72°C after the final cycle. The fragments were purified using the QIAquick PCR Purification Kit (Qiagen). Products were pooled and subjected to digestion by Cfo I (25 U) for 45 min at 37°C, purified with the PCR Purification Kit and eluted with 30 µ L H 2 O. The ligation was conducted at 37°C for 45 min with the addition of 1 U T4 DNA ligase to the pooled digestion products. The ligation product was electrophoresed (1.5% agarose), and the desired 1050-bp fragment was excised and purified as required by the QIAquick Gel Extraction Kit and eluted into 30 µ L of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0).
The PCR fragment was cloned into the pGEM-T PCR vector. Excised fragment (2.5 µ L) was combined with 1 µ L pGEM-T vector with 1 U T4 DNA ligase and ligation buffer and held overnight at 4°C. The ligation product was transformed into high-efficiency HMS-174 competent cells, and 100 µ L of transformation mixture were plated on LB/ampicillin (50 µ g/mL) with X-gal to grow overnight. Sixteen isolated white colonies were selected for amplification in LB/ampicillin. Plasmids were extracted from 1.5 mL of overnight cultures using the QIAprep Spin Miniprep Kit. Plasmid DNA (5 µ L) was subjected to digestion by 10 U Apa I to confirm proper insertion of the mutant ligated fragment. A selected sample submitted for sequencing using the PCR primers demonstrates no undesired mutations.
The mutant fragment is used to construct Y196F-OYE1-pET from OYE1-pET by replacing the 690-bp cassette, which contains the mutation of interest between the Apa I and Bst XI sites. In the final product, unlike the product of the class 2S method of SDM, the Cfo I restriction site used to fuse the mutant overlapping fragments remains intact, and digestion allows for confirmation of proper incorporation of the mutant fragment.
A careful analysis of the target gene sequence and proper choice of primers are critical to the procedure (Figure 1 ). In the region to be mutated, we analyzed the upstream and downstream sequences to find the nearest unique restriction sites to the mutation point. In this manner, fidelity is maximized because the final fragment generated by PCR is of minimal size. Alternatively, a single enzyme with two restriction sites flanking the region to be mutated can be used. If no unique restriction sites exist within the gene of interest, the sites from a multiple cloning site can generally be used. Nonmutagenic PCR primers were designed to flank the region defined by the two selected restriction sites. To allow for sequencing BioTechniques 185 in the desired region, the primers are designed more than 40 bp past the restriction site. The ample variety of commercially available restriction endonucleases enlarges the number of possible silent mutations in the vicinity of the desired mutation. Optimally, the desired mutation can create a new restriction site into the mutagenic oligonucleotide, eliminating the need for a silent mutation. For OYE1 , although Cfo I has numerous restriction sites within the vector and insert, no other Cfo I sites exist within the short fragment generated by Bst XI/ Apa I digestion. The process of finding a possible silent mutation is simplified by the fact that the introduced restriction site need only be unique within the short fragment between the selected WT restriction sites. To guarantee efficient digestion with the restriction endonuclease, the recognition site should be spaced several residues from the end of the designed primer. In addition, silent mutations generating codons of low frequency in the species used for expression should be avoided to optimize translatability of the mutant protein (2) .
The procedure favors successful SDM in several ways. In this protocol, digestion of PCR products by Cfo I followed by ligation to form the fused mutated insert selects for only those fragments that have successfully incorporated the mutagenic oligonucleotide. The 1-bp overhang generated by Taq DNA polymerase benefits this SDM procedure by allowing for TA-based cloning of the fused mutant insert into the pGEM-T vector, followed by amplification of the fused PCR fragment in E. coli . Using a mixture of Taqand Pfupolymerases, which has been reported to increase fidelity while maintaining 3 ′ A overhangs from Taq , could potentially benefit the application of this method (1). The procedure can be streamlined by bypassing the pGEM-T vector by digesting the ligation product with Apa I and Bst XI and replacing the mutated cassette directly into plasmid OYE1-pET. This, however, requires generation of a sufficient amount of the digested, fused fragment to conduct a successful ligation. Use of the pGEM-T vector is advantageous because the use of the natural machinery of replication guarantees DNA fidelity and avoids difficulties associated with methods calling for a second round of PCR for fusion of fragments. In addition, insertion into the PCR vector allows for screening of the mutation at an early step by sequencing and analytical restriction endonuclease digestion. Cfo I digestion of plasmid miniprep samples demonstrates that all have incorporated the desired mutation. Also, sequencing of the fragment encompassing the Y196F mutation shows no undesired mutations between the ApaI andBst XI Taxol ® (Bristol-Meyers Squibb, New York, NY, USA) is a phenolic compound derived from the pacific yew Taxus brevifolia(7) that promotes microtubule assembly and enhances microtubule stability in the presence of cold and calcium ion (3) (4) (5) . Taxol was first reported as a compound that possessed anti-tumor activity by Wani et al. in 1971 (7) . It has since proven to be an essential tool in studies of microtubules, including the recent resolution of tubulin's three-dimensional structure (3) . Taxol binds to a site within the intermediate domain of β -tubulin subunits in a region that can promote α / β subunit interactions. Its binding site is located within a region away from the presumed surface on which motor molecules travel and microtubule-associated proteins bind (3) .
Tubulin directly conjugated with a fluorochrome, such as tetramethylrhodamine, and microinjected into living cells has greatly extended our knowledge of microtubule patterning, array shifts and kinetics (2, 6) . Although these kinds of in vivo assays do not normally use taxol as a stabilizing agent, there are in vitro microtubulebased assays that require or are greatly facilitated by taxol stabilization (1) . Studies characterizing isolated microtubule motor molecules are the most familiar of these assays. Observations of microtubule gliding can be performed with fluorescence microscopy using fluorochrome-tagged microtubules (1, 2) . Fluorescence methods offer the added advantage of polymerizing microtubules from brightly labeled 188BioTechniques 
